{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:03:19Z","timestamp":1791644599354,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.eprac.2021.11.083","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T02:26:57Z","timestamp":1637720817000},"page":"342-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Is the Neutrophil-to-Lymphocyte Ratio an Exceptional Indicator for Metabolic Syndrome Disease and Outcomes?"],"prefix":"10.1016","volume":"28","author":[{"given":"Parisa","family":"Hashemi Moghanjoughi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Neshat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyan","family":"Heshmat-Ghahdarijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.eprac.2021.11.083_bib1","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.2337\/diabetes.52.8.2160","article-title":"Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies","volume":"52","author":"Meigs","year":"2003","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.eprac.2021.11.083_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1076029612459675","article-title":"Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome","volume":"20","author":"Buyukkaya","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"10.1016\/j.eprac.2021.11.083_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12937-018-0417-z","article-title":"Association of dietary patterns, anthropometric measurements, and metabolic parameters with C-reactive protein and neutrophil-to-lymphocyte ratio in middle-aged and older adults with metabolic syndrome in Taiwan: a cross-sectional study","volume":"17","author":"Syauqy","year":"2018","journal-title":"Nutr J"},{"issue":"8","key":"10.1016\/j.eprac.2021.11.083_bib4","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jdiacomp.2016.08.006","article-title":"Association of neutrophil-lymphocyte ratio with metabolic syndrome and its components in Asian Indians (CURES-143)","volume":"30","author":"Surendar","year":"2016","journal-title":"J\u00a0Diabetes Complications"},{"issue":"43","key":"10.1016\/j.eprac.2021.11.083_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017537","article-title":"Neutrophil-to-lymphocyte ratio as a predictive marker of metabolic syndrome","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"2-3","key":"10.1016\/j.eprac.2021.11.083_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000356535","article-title":"Chronic low-grade inflammation in metabolic disorders: relevance for behavioral symptoms","volume":"21","author":"Lasselin","year":"2014","journal-title":"Neuroimmunomodulation"},{"issue":"7121","key":"10.1016\/j.eprac.2021.11.083_bib7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.eprac.2021.11.083_bib8","first-page":"459","article-title":"Inflammation and metabolic disorders","volume":"11","author":"Navab","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.eprac.2021.11.083_bib9","series-title":"Higher Neutrophil to Lymhocyte Ratio in Patients With Metabolic Syndrome","author":"Balta","year":"2013"},{"issue":"2","key":"10.1016\/j.eprac.2021.11.083_bib10","first-page":"581","article-title":"Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus","volume":"42","author":"Sefil","year":"2014","journal-title":"J\u00a0Int Med Res"},{"issue":"11","key":"10.1016\/j.eprac.2021.11.083_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112361","article-title":"Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects","volume":"9","author":"Azab","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.eprac.2021.11.083_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13104-016-2335-5","article-title":"What is the normal value of the neutrophil-to-lymphocyte ratio?","volume":"10","author":"Forget","year":"2017","journal-title":"BMC Res Notes"},{"issue":"3","key":"10.1016\/j.eprac.2021.11.083_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1684\/ecn.2018.0415","article-title":"Obesity and inflammation","volume":"29","author":"Karczewski","year":"2018","journal-title":"Eur Cytokine Netw"},{"issue":"11","key":"10.1016\/j.eprac.2021.11.083_bib14","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.molmet.2016.09.003","article-title":"Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity","volume":"5","author":"Tardelli","year":"2016","journal-title":"Mol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2021.11.083_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13085","article-title":"Neutrophil-to-lymphocyte ratio and its relation with pro-inflammatory mediators, visceral adiposity and carotid intima-media thickness in population with obesity","volume":"49","author":"Su\u00e1rez-Cuenca","year":"2019","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.eprac.2021.11.083_bib16","first-page":"195","article-title":"Relation between metabolic syndrome and neutrophil to lymphocyte ratio","volume":"33","author":"Copca-Nieto","year":"2017","journal-title":"Med Int Mex"},{"issue":"1","key":"10.1016\/j.eprac.2021.11.083_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5543\/tkda.2015.10594","article-title":"The relationship between neutrophil to lymphocyte ratio and blood pressure variability in hypertensive and normotensive subjects","volume":"43","author":"K\u0131l\u0131\u00e7aslan","year":"2015","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"2","key":"10.1016\/j.eprac.2021.11.083_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.repc.2016.07.009","article-title":"The relationship between 24-hour ambulatory blood pressure load and neutrophil-to-lymphocyte ratio","volume":"36","author":"\u00c7imen","year":"2017","journal-title":"Rev Port Cardiol"},{"issue":"2","key":"10.1016\/j.eprac.2021.11.083_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1536\/ihj.19-138","article-title":"NLR-A simple indicator of inflammation for the diagnosis of left ventricular hypertrophy in patients with hypertension","volume":"61","author":"Yu","year":"2020","journal-title":"Int Heart J"},{"issue":"8","key":"10.1016\/j.eprac.2021.11.083_bib20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41440-019-0245-3","article-title":"Neutrophil to lymphocyte ratio as predictor for incident hypertension: a 9-year cohort study in Taiwan","volume":"42","author":"Jhuang","year":"2019","journal-title":"Hypertens Res"},{"issue":"7","key":"10.1016\/j.eprac.2021.11.083_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/jch.12533","article-title":"Increased neutrophil to lymphocyte ratio in patients with resistant hypertension","volume":"17","author":"Belen","year":"2015","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"11","key":"10.1016\/j.eprac.2021.11.083_bib22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/qjmed\/hcs123","article-title":"The long-term predictive value of the neutrophil-to-lymphocyte ratio in type 2 diabetic patients presenting with acute myocardial infarction","volume":"105","author":"Lee","year":"2012","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.eprac.2021.11.083_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/0886022X.2011.641514","article-title":"The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients","volume":"34","author":"Turkmen","year":"2012","journal-title":"Ren Fail"},{"issue":"5","key":"10.1016\/j.eprac.2021.11.083_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1076029615569568","article-title":"The relation between atherosclerosis and the neutrophil\u2013lymphocyte ratio","volume":"22","author":"Balta","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.eprac.2021.11.083_bib25","first-page":"686791","article-title":"Association of high density lipoprotein with platelet to lymphocyte and neutrophil to lymphocyte ratios in coronary artery disease patients","volume":"2014","author":"Prajapati","year":"2014","journal-title":"J\u00a0Lipids"},{"issue":"6","key":"10.1016\/j.eprac.2021.11.083_bib26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0003319715604098","article-title":"Statin therapy may not effect NLR and MPV levels in patients with hypercholesterolemia: a retrospective study","volume":"67","author":"Gungoren","year":"2016","journal-title":"Angiology"},{"issue":"2","key":"10.1016\/j.eprac.2021.11.083_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1056-8727(96)00090-6","article-title":"The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome","volume":"11","author":"Zimmet","year":"1997","journal-title":"J\u00a0Diabetes Complications"},{"issue":"6","key":"10.1016\/j.eprac.2021.11.083_bib28","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.2337\/diacare.26.6.1922","article-title":"Inflammation and insulin resistance","volume":"26","author":"Bloomgarden","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2021.11.083_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12902-015-0002-9","article-title":"Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients","volume":"15","author":"Lou","year":"2015","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"10.1016\/j.eprac.2021.11.083_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s13410-017-0550-9","article-title":"The relationship between neutrophil to lymphocyte ratio and metabolic syndrome in patients with type 2 diabetes","volume":"37","author":"Kaya","year":"2017","journal-title":"Int J Diabetes Dev C"},{"issue":"8","key":"10.1016\/j.eprac.2021.11.083_bib31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1089\/dia.2013.0264","article-title":"Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes","volume":"16","author":"Shiny","year":"2014","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"10.1016\/j.eprac.2021.11.083_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/ajim.ajim_102_20","article-title":"A\u00a0study of neutrophil-to-lymphocyte ratio in patients with metabolic syndrome","volume":"9","author":"Mohan","year":"2021","journal-title":"APIK J Int Med"},{"key":"10.1016\/j.eprac.2021.11.083_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2147\/DMSO.S238990","article-title":"Comparison of the value of neutrophil to high-density lipoprotein cholesterol ratio and lymphocyte to high-density lipoprotein cholesterol ratio for predicting metabolic syndrome among a population in the southern coast of China","volume":"13","author":"Chen","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"6","key":"10.1016\/j.eprac.2021.11.083_bib34","first-page":"956","article-title":"Is an elevated neutrophil-to-lymphocyte ratio a predictor of metabolic syndrome in patients with chronic obstructive pulmonary disease?","volume":"19","author":"Yasar","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"10.1016\/j.eprac.2021.11.083_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23935","article-title":"Distribution and reference interval establishment of neutral-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in Chinese healthy adults","volume":"35","author":"Wang","year":"2021","journal-title":"J\u00a0Clin Lab Anal"},{"issue":"1","key":"10.1016\/j.eprac.2021.11.083_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0033-1361087","article-title":"Benefits of the neutrophil-to-lymphocyte ratio for the prediction of gestational diabetes mellitus in pregnant women","volume":"122","author":"Yilmaz","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"10.1016\/j.eprac.2021.11.083_bib37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.dsx.2014.04.009","article-title":"Usefulness of the neutrophil-to-lymphocyte ratio to prediction of type 2 diabetes mellitus in morbid obesity","volume":"9","author":"Yilmaz","year":"2015","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10.1016\/j.eprac.2021.11.083_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1755-7682-5-2","article-title":"Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population","volume":"5","author":"Imtiaz","year":"2012","journal-title":"Int Arch Med"},{"issue":"10","key":"10.1016\/j.eprac.2021.11.083_bib39","doi-asserted-by":"crossref","first-page":"816","DOI":"10.5152\/akd.2014.5787","article-title":"Is the neutrophil-to-lymphocyte ratio indicative of inflammatory state in patients with obesity and metabolic syndrome?","volume":"15","author":"Bahad\u0131r","year":"2015","journal-title":"Anatol J Cardiol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21013811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21013811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:13:34Z","timestamp":1761516814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X21013811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1530891X21013811"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2021.11.083","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the Neutrophil-to-Lymphocyte Ratio an Exceptional Indicator for Metabolic Syndrome Disease and Outcomes?","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2021.11.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}